Denali Therapeutics Inc. Reports annual revenue of $330.5 million
Company Records $145,224,000.0 loss
By USInMinutes
Published - Feb 29, 2024, 04:46 AM ET
Last Updated - Feb 29, 2024, 04:46 AM EST
Denali Therapeutics Inc. [DNLI] has reported $330.5 million in revenue for year ended Dec 31, 2023.
Also Read:
